BNA Publications

– Le Duff F, Develay AE, Quetel J, Lafay P, Schuck S, Pradier C, et al. The 2008-2012 French Alzheimer plan: description of the national Alzheimer information system. Journal of Alzheimer’s disease : JAD. 2012;29(4):891-902.

– Tifratene K, Duff FL, Pradier C, Quetel J, Lafay P, Schuck S, et al. Use of drug treatments for Alzheimer’s disease in France: a study on a national level based on the National Alzheimer’s Data Bank (Banque Nationale Alzheimer). Pharmacoepidemiol Drug Saf. 2012;21(9):1005-12.

– Anthony S, Pradier C, Chevrier R, Festraets J, Tifratene K, Robert P. The French National Alzheimer Database: A Fast Growing Database for Researchers and Clinicians. Dementia and geriatric cognitive disorders. 2014;38(5-6):271-80.

– Tifratene K, Sakarovitch C, Rouis A, Pradier C, Robert P. Mild cognitive impairment and anti-Alzheimer disease medications: A cross sectional study of the French National Alzheimer Databank (BNA). Journal of Alzheimer’s disease : JAD. 2014;38(3):541-9.

– Pradier C, Sakarovitch C, Le Duff F, Layese R, Metelkina A, Anthony S, et al. The Mini Mental State Examination at the Time of Alzheimer’s Disease and Related Disorders Diagnosis, According to Age, Education, Gender and Place of Residence: A Cross-Sectional Study among the French National Alzheimer Database. PloS one. 2014;9(8):e103630.

– Troussiere AC, Wallon D, Mouton-Liger F, Yatimi R, Robert P, Hugon J, et al. Who needs cerebrospinal biomarkers? A national survey in clinical practice. Journal of Alzheimer’s disease : JAD. 2014;40(4):857-61.

– Tifratene K, Robert P, Metelkina A, Pradier C, Dartigues JF. Progression of mild cognitive impairment to dementia due to AD in clinical settings. Neurology. 2015;85(4):331-8.

– David R, Manera V, Fabre R, Pradier C, Robert P, Tifratene K. Evolution of the Antidepressant Prescribing in Alzheimer’s Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer’s Disease (BNA). Journal of Alzheimer’s disease : JAD. 2016;53(4):1365-73.

– Tifratene K, Manera V, Fabre R, Gros A, Thummler S, Pradier C, et al. Antipsychotic prescribing for Alzheimer’s disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study. Alzheimer’s research & therapy. 2017;9(1):34.

 

Click on the link to access to a full BNA description / cliquer sur le lien pour accéder à la description complete de la BNA (en anglais)

Click on the link to access to the PLOS ONE article / cliquer sur le lien pour accéder à l’article de PLOS ONE